West Pharmaceutical Services Inc. closed 20.09% short of its 52-week high of $413.56, which the company reached on February ...

The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...

The stock's rise snapped a three-day losing streak.

West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are presently covering the firm, Ratings ...

West Pharmaceutical Services has a 12 month low of $265.00 and a 12 month high of $413.70. The firm has a fifty day simple moving average of $332.25 and a 200-day simple moving average of $314.42.

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/7/25, West Pharmaceutical Services, Inc. (Symbol: WST), SouthState Corp (Symbol: SSB), and Pinnacle Financial Partners Inc ...

West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Expanding market reach to drive organic revenue growth without equity dilutionCollaborating with AI-driven health assessments and customized ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...